Nicholas P. Greene Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI High Impact

Associate Professor

Last publication 2025 Last refreshed 2026-05-22

faculty

29 h-index 186 pubs 3,857 cited

Biography and Research Information

OverviewAI-generated summary

Nicholas P. Greene's research focuses on skeletal muscle physiology, with a particular emphasis on the molecular mechanisms underlying muscle atrophy and adaptation. His work investigates how conditions such as cancer cachexia and disuse impact muscle at the cellular and molecular levels, examining factors like mitochondrial stress and transcriptional disruptions. Greene has explored sex-based differences in the development of muscle atrophy and the response to stimuli like exercise and aging.

His federally funded work includes a $313,850 grant from the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases for the "DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA." Greene has authored or co-authored 187 publications with a total of 3,827 citations, and maintains an h-index of 28. He is recognized as a high-impact researcher and a federal grant principal investigator. Greene actively collaborates with researchers at the University of Arkansas at Fayetteville, including Francielly Morena da Silva, Tyrone A. Washington, Ana Regina Cabrera, and Eleanor R. Schrems, with whom he shares numerous publications.

Metrics

  • h-index: 29
  • Publications: 186
  • Citations: 3,857

Selected Publications

  • The Age‐Dependent Resident Myonuclear Multi‐Omic Response to an Acute Skeletal Muscle Hypertrophic Stimulus in Mice (2026)
  • Exercise-induced antioxidant programming in oxidative muscle: a critical IL1β-NBR1-p62 axis (2026)
  • Skeletal muscle methylome-transcriptome disruptions during the onset and progression of colorectal cancer-induced cachexia (2025)
    1 citation DOI OpenAlex
  • The Age-Dependent Resident Myonuclear Multi-Omic Response to a Skeletal Muscle Hypertrophic Stimulus (2025)
    1 citation DOI OpenAlex
  • Mitochondrial-targeted plastoquinone therapy prevents early onset muscle weakness that occurs before atrophy during ovarian cancer (2025)
    2 citations DOI OpenAlex
  • Sustained Accumulation of Molecular Clock Suppressors Period 1 and Period 2 Promotes C2C12 Myotube Atrophy Through an Autocrine-Mediated Mechanism With Relevance to Androgen Deprivation-Induced Limb Muscle Mass Loss (2025)
    3 citations DOI OpenAlex
  • Myocellular adaptations to short‐term weighted wheel‐running exercise are largely conserved during C26‐tumour induction in male and female mice (2025)
    2 citations DOI OpenAlex
  • Landscape of Clinical Trials in Cancer Cachexia: Assessment of Trends From 1995-2024 (2025)
    1 citation DOI OpenAlex
  • The 24-hour molecular landscape after exercise in humans reveals MYC is sufficient for muscle growth (2024)
    19 citations DOI OpenAlex
  • Transcriptional analysis of cancer cachexia: conserved and unique features across preclinical models and biological sex (2024)
    7 citations DOI OpenAlex
  • Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice (2024)
    1 citation DOI OpenAlex
  • Mitochondrial antioxidant SkQ1 attenuates C26 cancer-induced muscle wasting in males and improves muscle contractility in female tumor-bearing mice (2024)
    11 citations DOI OpenAlex
  • Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia (2024)
    12 citations DOI OpenAlex
  • Exploring heterogeneity: a dive into preclinical models of cancer cachexia (2024)
    10 citations DOI OpenAlex
  • Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexia (2024)
    2 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $313,850 total

NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases Contact PI Jul 2020 - Jun 2026

DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA

National Institute of Arthritis and Musculoskeletal and Skin Diseases $313,850 R01

Collaboration Network

159 Collaborators 38 Institutions 4 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics